SCHEMBL25976556

SCHEMBL25976556

Cc1c[n+](C)c(-c2cc(-c3ccccc3)ccc2C)cc1-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
KDM4E B2RXH2 3/20 0.36
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2D6 P10635 1/20 0.35
RAB9A P51151 5/20 0.35
NPC1 O15118 4/20 0.35
KMT2A Q03164 3/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPRT1 P00492 1/20 0.35
ALOX5 P09917 1/20 0.34
ESR2 Q92731 1/20 0.34
APAF1 O14727 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25976558 0.91 SLC6A9 (0.38) HTTSMN1; SMN2KDM4ECYP1A2CYP3A4
SCHEMBL25976918 0.91 CA12 (0.40) KDM4ECYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL25452197 0.89 HTT (0.37) HTTSMN1; SMN2KDM4ECYP1A2CYP3A4
SCHEMBL25976595 0.88 TYMS (0.36) HTTSMN1; SMN2KDM4ECYP1A2CYP3A4
SCHEMBL25976598 0.87 PSMB5 (0.35) HTTSMN1; SMN2KDM4ECYP1A2CYP3A4
SCHEMBL25976597 0.86 RAB9A (0.39) HTTSMN1; SMN2KDM4ECYP1A2CYP3A4
SCHEMBL25976376 0.85 HTT (0.34) HTTSMN1; SMN2KDM4ECYP1A2CYP3A4
SCHEMBL25446047 0.85 SMN1; SMN2 (0.38) HTTSMN1; SMN2KDM4ERAB9ANPC1
SCHEMBL25446098 0.85 ESR2 (0.41) HTTSMN1; SMN2KDM4ERAB9ANPC1
SCHEMBL25976656 0.82 ESR2 (0.36) HTTSMN1; SMN2KDM4ERAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed
US-11725021-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725021-B2 Organic electroluminescent materials and devices NCL, OCIAD2, OCIAD1 HTT 3085/4885SMN1; SMN2 3169/4885KDM4E 3735/4885
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NCL, OCIAD2, OCIAD1 HTT 3085/4885SMN1; SMN2 3169/4885KDM4E 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.